92 related articles for article (PubMed ID: 20096670)
1. The expression profile of FRAT1 in human gliomas.
Guo G; Mao X; Wang P; Liu B; Zhang X; Jiang X; Zhong C; Huo J; Jin J; Zhuo Y
Brain Res; 2010 Mar; 1320():152-8. PubMed ID: 20096670
[TBL] [Abstract][Full Text] [Related]
2. FRAT1 expression and its correlation with pathologic grade, proliferation, and apoptosis in human astrocytomas.
Guo G; Liu B; Zhong C; Zhang X; Mao X; Wang P; Jiang X; Huo J; Jin J; Liu X; Chen X
Med Oncol; 2011 Mar; 28(1):1-6. PubMed ID: 20041315
[TBL] [Abstract][Full Text] [Related]
3. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer.
Saitoh T; Mine T; Katoh M
Int J Oncol; 2002 Apr; 20(4):785-9. PubMed ID: 11894125
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of FRAT1 is associated with malignant phenotype and poor prognosis in human gliomas.
Guo G; Zhong CL; Liu Y; Mao XG; Zhang Z; Jin J; Liu J; Yang L; Mao JM; Guo YH; Zhao YL
Dis Markers; 2015; 2015():289750. PubMed ID: 25922553
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.
Guo G; Kuai D; Cai S; Xue N; Liu Y; Hao J; Fan Y; Jin J; Mao X; Liu B; Zhong C; Zhang X; Yue Y; Liu X; Ma N; Guo Y
PLoS One; 2013; 8(4):e61206. PubMed ID: 23613813
[TBL] [Abstract][Full Text] [Related]
7. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
8. [Expression of SV40Tag, Rb and IRS-1 in glioma detected by tissue microarray and their relation with tumorigenesis and progression of gliomas].
Qian ZY; Wu YY; Huang Q; Zhai DZ; Zhu Q; Wang AD; Huo HM; Lan Q
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):432-6. PubMed ID: 19024517
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
11. [Significance of beta-catenin and Cyclin D1 express in glioma].
Zhang ZQ; Chen HQ; Chen YH; Cheng XF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):1010-2. PubMed ID: 19900369
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
13. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
15. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.
Zhao Y; Xue Y; Liu Y; Fu W; Jiang N; An P; Wang P; Yang Z; Wang Y
Br J Neurosurg; 2005 Aug; 19(4):322-6. PubMed ID: 16455538
[TBL] [Abstract][Full Text] [Related]
16. Notch1 expression is upregulated in glioma and is associated with tumor progression.
Jiang L; Wu J; Chen Q; Hu X; Li W; Hu G
J Clin Neurosci; 2011 Mar; 18(3):387-90. PubMed ID: 21251836
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
Wang DL; Wang YF; Shi GS; Huang H
Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
19. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
Mueller W; Lass U; Wellmann S; Kunitz F; von Deimling A
Acta Neuropathol; 2005 Mar; 109(3):314-20. PubMed ID: 15668788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]